Harvard Bioscience, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.98 M | $6.29 M | 2.24% | 6.84% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 2.76 M | $5.81 M | -0.62% | 6.32% |
HARVEY PARTNERS, LLC | 02/14/2025 | 2.68 M | $5.66 M | -1.18% | 6.15% |
AMH EQUITY LTD | 02/05/2025 | 2.50 M | $5.28 M | 4.65% | 5.73% |
VANGUARD GROUP INC | 02/11/2025 | 2.16 M | $4.55 M | 0.18% | 4.95% |
ROYCE & ASSOCIATES LP | 02/10/2025 | 1.97 M | $4.15 M | 35.39% | 4.51% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.67 M | $3.51 M | -2.96% | 3.82% |
GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 1.62 M | $3.41 M | -13.31% | 3.71% |
B. RILEY ASSET MANAGEMENT, LLC | 02/14/2025 | 1.35 M | $2.85 M | -12.01% | 3.10% |
HEARTLAND ADVISORS INC | 02/12/2025 | 1.20 M | $2.53 M | 0.00% | 2.75% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 1.15 M | $2.43 M | -13.81% | 2.64% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 998,793 | $2.10 M | 14.33% | 2.29% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 919,069 | $1.94 M | 0.71% | 2.11% |
MEROS INVESTMENT MANAGEMENT, LP | 02/14/2025 | 813,707 | $1.72 M | -2.39% | 1.87% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 709,778 | $1.50 M | -1.97% | 1.63% |
ACUITAS INVESTMENTS, LLC | 01/31/2025 | 491,092 | $1.04 M | 0.00% | 1.13% |
BARD ASSOCIATES INC | 02/06/2025 | 267,699 | $564,845 | -14.31% | 0.61% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 239,696 | $505,759 | 0.00% | 0.55% |
GREENWOOD CAPITAL ASSOCIATES LLC | 01/27/2025 | 216,298 | $456,389 | -4.24% | 0.50% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 209,548 | $442,147 | -8.92% | 0.48% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 200,032 | $422,068 | 11.13% | 0.46% |
PASADENA PRIVATE WEALTH, LLC | 02/03/2025 | 198,039 | $417,862 | 0.00% | 0.45% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 197,404 | $416,522 | 12.53% | 0.45% |
PANAGORA ASSET MANAGEMENT INC | 02/13/2025 | 164,008 | $346,057 | 73.06% | 0.38% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 139,999 | $295,398 | 0.00% | 0.32% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 129,317 | $272,859 | -29.91% | 0.30% |
JPMORGAN CHASE & CO | 02/12/2025 | 113,591 | $239,676 | 285.04% | 0.26% |
WILLIAMS & NOVAK, LLC | 01/23/2025 | 99,210 | $209,333 | 100.00% | 0.23% |
GAMCO INVESTORS, INC. ET AL | 02/13/2025 | 95,000 | $200,450 | 100.00% | 0.22% |
ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 69,799 | $147,276 | -65.50% | 0.16% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 66,204 | $139,690 | -11.35% | 0.15% |
GABELLI FUNDS LLC | 02/13/2025 | 65,000 | $137,150 | 8.33% | 0.15% |
BARCLAYS PLC | 02/13/2025 | 62,162 | $131,000 | 5.98% | 0.14% |
RHUMBLINE ADVISERS | 01/30/2025 | 39,437 | $83,203 | 1.83% | 0.09% |
UBS GROUP AG | 02/14/2025 | 37,167 | $78,423 | 79.36% | 0.09% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 35,817 | $75,574 | 6.26% | 0.08% |
JANE STREET GROUP, LLC | 02/14/2025 | 35,769 | $75,472 | 55.50% | 0.08% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 35,456 | $74,812 | 100.00% | 0.08% |
CITIGROUP INC | 02/12/2025 | 32,358 | $68,275 | 7.73% | 0.07% |
VERITION FUND MANAGEMENT LLC | 02/14/2025 | 32,160 | $67,858 | -5.45% | 0.07% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 28,556 | $60,253 | -28.53% | 0.07% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 28,209 | $60,000 | 155.35% | 0.06% |
BRIGHTON JONES LLC | 03/04/2025 | 25,000 | $52,750 | -1.44% | 0.06% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 24,310 | $51,294 | 4.24% | 0.06% |
DEUTSCHE BANK AG\ | 02/14/2025 | 23,666 | $49,935 | 0.00% | 0.05% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 22,658 | $47,808 | 23.83% | 0.05% |
SEI INVESTMENTS CO | 02/11/2025 | 22,268 | $46,985 | 100.00% | 0.05% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 20,263 | $42,755 | -7.02% | 0.05% |
INVESCO LTD. | 02/13/2025 | 17,404 | $36,723 | 7.95% | 0.04% |
NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 16,842 | $36,000 | 0.00% | 0.04% |
Harvard Bioscience, Inc. institutional Ownership - FAQ's
During the previous two years, 128 institutional investors and hedge funds held shares of Harvard Bioscience, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 2.98 M
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.: 2.76 M
Harvey Partners, LLC: 2.68 M
AMH Equity Ltd: 2.5 M
VANGUARD GROUP INC: 2.16 M
ROYCE & ASSOCIATES LP: 1.97 M
70.68% of Harvard Bioscience, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 37.73 M shares in the last 24 months. This purchase volume represents approximately $82.63 M in transactions.